The American Kidney Fund is providing emergency financial aid to patients impacted by the California wildfires. A study identified modifiable dialysis-related factors associated with fatigue and dialysis recovery time. Sarah Tolson shares what billing departments of dialysis programs need to know about the CMS final rule for the ESRD PPS. A study documented findings on vitamin D and metabolic bone disease in children requiring prolonged CKRT. A study examined prognosis and lifespan of adults who received kidney replacement therapy as children. How did older adults with kidney failure fare with dialysis compared to medical management? CMS issued a final rule on the ESRD Prospective Payment System, which will raise payment rates and cover oral-only drugs. Dietitian Jessica Strawn offers tips on how to prevent dialysis patient hospitalizations during the holidays. Silvi Shah will receive the 2024 Dr. Nanette K. Wenger Research Goes Red Award from the American Heart Association. Dietitian Jessica Strawn shares suggestions for helping patients on dialysis choose protein supplement sources. Under a new agreement with Akebia, US Renal Care will be able to prescribe Vafseo to dialysis patients with anemia of CKD. Researchers examined rates of incident dialysis and acute kidney injury among patients after heart failure hospitalization. A bipartisan bill was introduced in the US Senate to ensure ESRD patients can access kidney care through private insurance. A dietitian studied the effects of education and protein bar consumption on albumin levels in dialysis patients. Researchers examined how work system design might contribute to infection prevention efforts in outpatient dialysis centers. The ISN and Centre for Sustainable Healthcare have partnered to promote environmentally sustainable kidney care practices. Are kidneys from donors who had dialysis more likely to result in adverse outcomes for transplant recipients? Researchers examined how cardiovascular health status differs between men and women with kidney failure. Ardelyx is suing the HHS and CMS over their addition of oral phosphate-lowering drugs to a bundled payment system. DaVita has agreed to pay $34,487,390 to resolve allegations that it paid illegal kickbacks.